Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA. 

Biotechnology

Health Care

Life Sciences

Zura Bio

Zura Bio's headquarters in Henderson, United States

Someit Sidhu

Kiran Nistala

Rob Lisicki

Verender Badial

Kim Davis

Gary Whale

Description

People (9)

Steve Schoch

Kim Davis

Rob Lisicki

Sandeep Kulkarni

Shannon Kenealy Carter

Marlyn Mathew

Janette Lo

Brandon Walsh

Malina Munshi

Jobs